Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China flag China · Delayed Price · Currency is CNY
11.70
-0.05 (-0.43%)
Feb 4, 2026, 1:14 PM CST

Hunan Fangsheng Pharmaceutical Company Description

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.

The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs.

The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue capsules, Lysine Vitamin B12 granules, Cefuroxime tablets, Jinying capsules, Pudilan anti-inflammatory tablets, Xiaoer Jingxing cough granules, Ezetimibe tablets, Xuanqi bone-strengthening tablets, Qiangli Loquat Paste (honey-refined), and Qiangli Loquat Dew and others.

It also offers other businesses, such as medical services, pharmaceutical commerce, and drug sales. The company was founded in 2002 and is based in Changsha, China.

Hunan Fangsheng Pharmaceutical Co., Ltd.
CountryChina
Founded2002
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,807
CEOXiaoli Zhou

Contact Details

Address:
No. 299, Jiayun Road
Changsha, Hunan Province 410205
China
Websitefangsheng.com.cn

Stock Details

Ticker Symbol603998
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001VG6
SIC Code2834

Key Executives

NamePosition
Xiaoli ZhouGM and Chairman
Chen BoDeputy GM and Director
Shi HeBoard Secretary
Xiangqi CaoFinancial Director and Accounting Supervisor